Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer

Both ferroptosis and lncRNAs are significant for ovarian cancer (OC). Whereas, the study of ferroptosis-related lncRNAs (FRLs) still few in ovarian cancer. We first constructed an FRL-signature for patients with OC in the study. A total of 548 FRLs were identified for univariate Cox regression analy...

Full description

Bibliographic Details
Main Authors: Jianfeng Zheng, Jialu Guo, Yahui Wang, Yingling Zheng, Ke Zhang, Jinyi Tong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.735871/full
_version_ 1798021783650041856
author Jianfeng Zheng
Jianfeng Zheng
Jialu Guo
Yahui Wang
Yingling Zheng
Ke Zhang
Jinyi Tong
Jinyi Tong
author_facet Jianfeng Zheng
Jianfeng Zheng
Jialu Guo
Yahui Wang
Yingling Zheng
Ke Zhang
Jinyi Tong
Jinyi Tong
author_sort Jianfeng Zheng
collection DOAJ
description Both ferroptosis and lncRNAs are significant for ovarian cancer (OC). Whereas, the study of ferroptosis-related lncRNAs (FRLs) still few in ovarian cancer. We first constructed an FRL-signature for patients with OC in the study. A total of 548 FRLs were identified for univariate Cox regression analysis, and 21 FRLs with significant prognosis were identified. The prognostic characteristics of nine FRLs was constructed and validated, showing opposite prognosis in two subgroups based on risk scores. The multivariate Cox regression analysis and nomogram further verified the prognostic value of the risk model. By calculating ferroptosis score through ssGSEA, we found that patients with higher risk scores exhibited higher ferroptosis scores, and high ferroptosis score was a risk factor. There were 40 microenvironment cells with significant differences in the two groups, and the difference of Stromal score between the two groups was statistically significant. Six immune checkpoint genes were expressed at different levels in the two groups. In addition, five m6A regulators (FMR1, HNRNPC, METTL16, METTL3, and METTL5) were higher expressed in the low-risk group. GSEA revealed that the risk model was associated with tumor-related pathways and immune-associated pathway. We compared the sensitivity of chemotherapy drugs between the two risk groups. We also explored the co-expression, ceRNA relation, cis and trans interaction of ferroptosis-related genes and lncRNAs, providing a new idea for the regulatory mechanisms of FRLs. Moreover, the nine FRLs were selected for detecting their expression levels in OC cells and tissues.
first_indexed 2024-04-11T17:19:13Z
format Article
id doaj.art-8b400ce975074d7195a9a752789d2762
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-11T17:19:13Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-8b400ce975074d7195a9a752789d27622022-12-22T04:12:32ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-01-01810.3389/fmolb.2021.735871735871Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian CancerJianfeng Zheng0Jianfeng Zheng1Jialu Guo2Yahui Wang3Yingling Zheng4Ke Zhang5Jinyi Tong6Jinyi Tong7Department of Obstetrics and Gynecology, Affiliated Hangzhou Hospital, Nanjing Medical University, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Hangzhou Women’s Hospital, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Hangzhou Women’s Hospital, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hangzhou Hospital, Nanjing Medical University, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hangzhou Hospital, Nanjing Medical University, Hangzhou, ChinaDepartment of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hangzhou Hospital, Nanjing Medical University, Hangzhou, ChinaDepartment of Obstetrics and Gynecology, Hangzhou Women’s Hospital, Hangzhou, ChinaBoth ferroptosis and lncRNAs are significant for ovarian cancer (OC). Whereas, the study of ferroptosis-related lncRNAs (FRLs) still few in ovarian cancer. We first constructed an FRL-signature for patients with OC in the study. A total of 548 FRLs were identified for univariate Cox regression analysis, and 21 FRLs with significant prognosis were identified. The prognostic characteristics of nine FRLs was constructed and validated, showing opposite prognosis in two subgroups based on risk scores. The multivariate Cox regression analysis and nomogram further verified the prognostic value of the risk model. By calculating ferroptosis score through ssGSEA, we found that patients with higher risk scores exhibited higher ferroptosis scores, and high ferroptosis score was a risk factor. There were 40 microenvironment cells with significant differences in the two groups, and the difference of Stromal score between the two groups was statistically significant. Six immune checkpoint genes were expressed at different levels in the two groups. In addition, five m6A regulators (FMR1, HNRNPC, METTL16, METTL3, and METTL5) were higher expressed in the low-risk group. GSEA revealed that the risk model was associated with tumor-related pathways and immune-associated pathway. We compared the sensitivity of chemotherapy drugs between the two risk groups. We also explored the co-expression, ceRNA relation, cis and trans interaction of ferroptosis-related genes and lncRNAs, providing a new idea for the regulatory mechanisms of FRLs. Moreover, the nine FRLs were selected for detecting their expression levels in OC cells and tissues.https://www.frontiersin.org/articles/10.3389/fmolb.2021.735871/fullovarian cancerferroptosislncRNArisk modelimmune
spellingShingle Jianfeng Zheng
Jianfeng Zheng
Jialu Guo
Yahui Wang
Yingling Zheng
Ke Zhang
Jinyi Tong
Jinyi Tong
Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
Frontiers in Molecular Biosciences
ovarian cancer
ferroptosis
lncRNA
risk model
immune
title Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
title_full Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
title_fullStr Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
title_full_unstemmed Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
title_short Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
title_sort bioinformatic analyses of the ferroptosis related lncrnas signature for ovarian cancer
topic ovarian cancer
ferroptosis
lncRNA
risk model
immune
url https://www.frontiersin.org/articles/10.3389/fmolb.2021.735871/full
work_keys_str_mv AT jianfengzheng bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT jianfengzheng bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT jialuguo bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT yahuiwang bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT yinglingzheng bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT kezhang bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT jinyitong bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer
AT jinyitong bioinformaticanalysesoftheferroptosisrelatedlncrnassignatureforovariancancer